PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-8.06%
Negative net income growth while MCHP stands at 8.44%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Slight usage while MCHP is negative at -73.37%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
100.00%
Some inventory rise while MCHP is negative at -119.25%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Some yoy usage while MCHP is negative at -58.91%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-107.78%
Negative yoy while MCHP is 2470.47%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
34.22%
Operating cash flow growth 1.25-1.5x MCHP's 24.61%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-63.53%
Both yoy lines negative, with MCHP at -12.21%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
32.10%
Purchases growth of 32.10% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
5.39%
Liquidation growth of 5.39% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-32.70%
We reduce yoy other investing while MCHP is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
26.41%
We have mild expansions while MCHP is negative at -12.21%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
168.42%
Lower share issuance yoy vs. MCHP's 857.91%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
35.29%
Buyback growth of 35.29% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.